C.J. Olbricht

776 total citations
20 papers, 503 citations indexed

About

C.J. Olbricht is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C.J. Olbricht has authored 20 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C.J. Olbricht's work include Lipoproteins and Cardiovascular Health (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Renal and Vascular Pathologies (3 papers). C.J. Olbricht is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Renal and Vascular Pathologies (3 papers). C.J. Olbricht collaborates with scholars based in Germany, Austria and United Kingdom. C.J. Olbricht's co-authors include K. M. Koch, Wilfried Gwinner, Rolf Bambauer, Oliver K. Eberhard, Ralf P. Brandes, Ulf Landmesser, P. Schuff‐Werner, Werner Richter, Giovannella Baggio and Maria Chiara Corti and has published in prestigious journals such as The Lancet, Journal of the American Society of Nephrology and American Journal of Physiology-Renal Physiology.

In The Last Decade

C.J. Olbricht

20 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.J. Olbricht Germany 10 256 116 97 89 74 20 503
Matthias Hoke Austria 15 151 0.6× 32 0.3× 168 1.7× 100 1.1× 85 1.1× 30 667
B Fellström Sweden 14 223 0.9× 194 1.7× 33 0.3× 94 1.1× 102 1.4× 38 557
Theodoros Kassimatis Greece 13 182 0.7× 135 1.2× 30 0.3× 78 0.9× 64 0.9× 29 445
Johanna Savikko Finland 13 178 0.7× 100 0.9× 41 0.4× 55 0.6× 44 0.6× 41 409
B.C. Jaques United Kingdom 10 305 1.2× 180 1.6× 30 0.3× 102 1.1× 30 0.4× 20 484
B.K. Shenton United Kingdom 12 675 2.6× 136 1.2× 346 3.6× 128 1.4× 90 1.2× 35 1.0k
E. McGregor United Kingdom 11 142 0.6× 75 0.6× 206 2.1× 87 1.0× 136 1.8× 17 638
John G. Vlachojannis Greece 15 90 0.4× 35 0.3× 49 0.5× 97 1.1× 326 4.4× 38 575
Ivo Lukitsch United States 7 194 0.8× 102 0.9× 40 0.4× 67 0.8× 164 2.2× 12 644
Linkun Hu China 14 105 0.4× 35 0.3× 28 0.3× 129 1.4× 89 1.2× 37 538

Countries citing papers authored by C.J. Olbricht

Since Specialization
Citations

This map shows the geographic impact of C.J. Olbricht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Olbricht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Olbricht more than expected).

Fields of papers citing papers by C.J. Olbricht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. Olbricht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Olbricht. The network helps show where C.J. Olbricht may publish in the future.

Co-authorship network of co-authors of C.J. Olbricht

This figure shows the co-authorship network connecting the top 25 collaborators of C.J. Olbricht. A scholar is included among the top collaborators of C.J. Olbricht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J. Olbricht. C.J. Olbricht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beck, Julia, Michael Oellerich, Uwe Schulz, et al.. (2015). Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation. Transplantation Proceedings. 47(8). 2400–2403. 100 indexed citations
3.
Krämer, Bernhard K., Daniel Del Castillo, R. Margreiter, et al.. (2008). Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. Nephrology Dialysis Transplantation. 23(7). 2386–2392. 44 indexed citations
4.
Olbricht, C.J., et al.. (2000). Hypokomplementämisches Urtikaria-Vaskulitis-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 125(34/35). 1003–1006. 4 indexed citations
5.
Siems, Werner, Wolfgang Henke, Klaus Jung, et al.. (1999). Metabolic Rates of 4-Hydroxynonenal in Tubular and Mesangial Cells of the Kidney. Nephron Experimental Nephrology. 7(1). 59–62. 5 indexed citations
6.
Olbricht, C.J.. (1998). Magnetic resonance angiography - the procedure of choice to diagnose renal artery stenosis?. Nephrology Dialysis Transplantation. 13(7). 1620–1622. 7 indexed citations
7.
Bambauer, Rolf, et al.. (1997). Low‐Density Lipoprotein Apheresis for Prevention and Regression of Atherosclerosis: Clinical Results. Therapeutic Apheresis. 1(3). 242–248. 26 indexed citations
8.
Gwinner, Wilfried, Ulf Landmesser, Ralf P. Brandes, et al.. (1997). Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.. Journal of the American Society of Nephrology. 8(11). 1722–1731. 74 indexed citations
9.
Gröne, H.-J., et al.. (1996). Characteristics of Renal Tubular Atrophy in Experimental Renovascular Hypertension: A Model of Kidney Hibernation. ˜The œNephron journals/Nephron journals. 72(2). 243–252. 17 indexed citations
10.
Schaumann, D., et al.. (1996). Prospective cross‐over comparisons of three low‐density lipoprotein (LDL)‐apheresis methods in patients with familial hypercholesterolaemia. European Journal of Clinical Investigation. 26(11). 1033–1038. 28 indexed citations
11.
Olbricht, C.J., et al.. (1995). Low-density-lipoprotein apheresis. The Lancet. 346(8967). 116–118. 9 indexed citations
13.
Galanski, M., et al.. (1994). Leistungsfähigkeit der CT-Angiographie beim Nachweis von Nierenarterienstenosen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 161(12). 519–525. 26 indexed citations
14.
Olbricht, C.J., et al.. (1992). Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption. Journal of Molecular Medicine. 70(2). 99–104. 9 indexed citations
15.
Olbricht, C.J., et al.. (1992). LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia.. PubMed. 37(3). M492–3. 3 indexed citations
16.
Olbricht, C.J.. (1991). Pathophysiologie und Therapie von Lipidstoffwechselstörungen bei Nierenerkrankungen. Journal of Molecular Medicine. 69(11). 455–462. 2 indexed citations
17.
Olbricht, C.J., et al.. (1990). [Bicarbonate instead of lactate buffered substitution solution for continuous hemofiltration in intensive care].. PubMed. 25(2). 164–7. 2 indexed citations
18.
Olbricht, C.J.. (1988). Effect of Glomerular Proteinuria on the Activities of Lysosomal Proteases in Isolated Segments of Rat Proximal Tubule. Advances in experimental medicine and biology. 240. 283–291. 1 indexed citations
19.
Olbricht, C.J., et al.. (1984). Acid phosphatase activity in the mammalian nephron. American Journal of Physiology-Renal Physiology. 247(2). F252–F259. 4 indexed citations
20.
Olbricht, C.J., et al.. (1982). Treatment of acute renal failure in patients with multiple organ failure by continuous spontaneous hemofiltration.. PubMed. 28. 33–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026